market access

Dark cinematic 16:9 banner with electric blue price corridor data visualisation and teal accents representing AI-driven pharma pricing strategy

AI Price Corridor Modeling: Stop Leaving Money on the Table at Launch

AI in Market Access and Pricing /

The MFN executive order and IRA have made pharma pricing a dynamic multi-market corridor management challenge. AI price corridor models continuously track IRP linkages, HTA outcomes, and launch sequence implications across markets. This article explains how biotech market access teams can build AI corridor modeling capability using publicly available data.

AI Price Corridor Modeling: Stop Leaving Money on the Table at Launch Read More »

Abstract visualization of pharmaceutical pricing data flowing through a distribution network

How AI Closes the $356 Billion Distributor Margin Gap in Biotech

AI in Biotech Commercial Operations /

The pharma gross-to-net bubble reached $356 billion in 2024, driven by rebates, chargebacks, and distributor fees. AI tools now enable real-time GTN monitoring, smarter distributor demand forecasting, and dynamic channel pricing. Companies adopting these approaches report 9% margin expansion and 17% better tender win rates.

How AI Closes the $356 Billion Distributor Margin Gap in Biotech Read More »